Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sarah, Paulin"'
Autor:
Isabel Frost, Anand Balachandran, Sarah Paulin-Deschenaux, Hatim Sati, Mateusz Hasso-Agopsowicz
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
Antimicrobial resistance (AMR) is a growing global problem and there were an estimated 4.95 million deaths associated with bacterial AMR worldwide in 2019. Vaccines can impact AMR by preventing infections and reducing the need for antibiotics which w
Externí odkaz:
https://doaj.org/article/0a648d4c950f45969328638897cf393b
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0236604 (2020)
The clinical pipeline continues to be insufficient to contain antimicrobial resistance, and further investment and research is needed to ensure that a robust pipeline is built to treat the WHO priority pathogens list of antibiotic-resistant bacteria.
Externí odkaz:
https://doaj.org/article/7e5fc0589a8e435e84d2751950f88f0f
Autor:
Gina Maki, Ingrid Smith, Sarah Paulin, Linda Kaljee, Watipaso Kasambara, Jessie Mlotha, Pem Chuki, Priscilla Rupali, Dipendra R. Singh, Deepak C. Bajracharya, Lisa Barrow, Eliaser Johnson, Tyler Prentiss, Marcus Zervos
Publikováno v:
Antibiotics, Vol 9, Iss 9, p 556 (2020)
Antimicrobial stewardship (AMS) has emerged as a systematic approach to optimize antimicrobial use and reduce antimicrobial resistance. To support the implementation of AMS programs, the World Health Organization developed a draft toolkit for health
Externí odkaz:
https://doaj.org/article/4fa33ca4624f457d990ba93e11db45ab
Autor:
Mark S. Butler, Valeria Gigante, Hatim Sati, Sarah Paulin, Laila Al-Sulaiman, John H. Rex, Prabhavathi Fernandes, Cesar A. Arias, Mical Paul, Guy E. Thwaites, Lloyd Czaplewski, Richard A. Alm, Christian Lienhardt, Melvin Spigelman, Lynn L. Silver, Norio Ohmagari, Roman Kozlov, Stephan Harbarth, Peter Beyer
Publikováno v:
Antimicrob Agents Chemother
There is an urgent global need for new strategies and drugs to control and treat multidrug-resistant bacterial infections. In 2017, the World Health Organization (WHO) released a list of 12 antibiotic-resistant priority pathogens and began to critica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76943be92776f3f4b8f59eb45535c2de
https://doi.org/10.1128/aac.01991-21
https://doi.org/10.1128/aac.01991-21
Autor:
Mark S, Butler, Valeria, Gigante, Hatim, Sati, Sarah, Paulin, Laila, Al-Sulaiman, John H, Rex, Prabhavathi, Fernandes, Cesar A, Arias, Mical, Paul, Guy E, Thwaites, Lloyd, Czaplewski, Richard A, Alm, Christian, Lienhardt, Melvin, Spigelman, Lynn L, Silver, Norio, Ohmagari, Roman, Kozlov, Stephan, Harbarth, Peter, Beyer
Publikováno v:
Antimicrob Agents Chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0b2db0b3fd1a34fe3ae36091dc172c77
https://pubmed.ncbi.nlm.nih.gov/35323013
https://pubmed.ncbi.nlm.nih.gov/35323013
Autor:
Sarah Paulin, Peter Beyer
Publikováno v:
ACS Infectious Diseases. 6:1289-1291
Despite ongoing efforts to stimulate investment and research into the development of new antibiotics, the clinical pipeline remains insufficient, in particular to treat critical resistant Gram-nega...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9aae558f7fd256904cdd412dc9ba9bf2
https://doi.org/10.1021/acsinfecdis.0c00044
https://doi.org/10.1021/acsinfecdis.0c00044
Autor:
Linda Kaljee, Sarah Paulin, Tyler Prentiss, Ingrid Smith, Gina Maki, Jessie Mlotha, Marcus J. Zervos, Watipaso Kasambara, Eliaser Johnson, Priscilla Rupali, Pem Chuki, Lisa Barrow, Deepak Bajracharya, Dipendra Raman Singh
Publikováno v:
Antibiotics
Antibiotics, Vol 9, Iss 556, p 556 (2020)
Volume 9
Issue 9
Antibiotics, Vol 9, Iss 556, p 556 (2020)
Volume 9
Issue 9
Antimicrobial stewardship (AMS) has emerged as a systematic approach to optimize antimicrobial use and reduce antimicrobial resistance. To support the implementation of AMS programs, the World Health Organization developed a draft toolkit for health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4303e762eff44b71ed3d7a735cea1586
http://europepmc.org/articles/PMC7558985
http://europepmc.org/articles/PMC7558985
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 7, p e0236604 (2020)
PLoS ONE, Vol 15, Iss 7, p e0236604 (2020)
The clinical pipeline continues to be insufficient to contain antimicrobial resistance, and further investment and research is needed to ensure that a robust pipeline is built to treat the WHO priority pathogens list of antibiotic-resistant bacteria.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::393bbba7a0ebec58187ffc6bcbc586fe
http://europepmc.org/articles/PMC7386594
http://europepmc.org/articles/PMC7386594
Autor:
Ingrid Smith, Dzintars Gotham, Sarah Paulin, Peter Beyer, Maarten van der Heijden, Lorenzo Moja
Publikováno v:
Health policy (Amsterdam, Netherlands). 125(3)
Introduction The pipeline of new antibacterials remains limited. Reasons include low research investments, limited commercial prospects, and scientific challenges. To complement existing initiatives such as research grants, governments are exploring
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf4f7f725c934bc1ccbeb91605648758
https://pubmed.ncbi.nlm.nih.gov/33402265
https://pubmed.ncbi.nlm.nih.gov/33402265
Publikováno v:
Bulletin of the World Health Organization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4a36facf27381c1b28f878cec3cda6f
https://doi.org/10.2471/blt.20.268573
https://doi.org/10.2471/blt.20.268573